FREMONT, Calif.–(BUSINESS WIRE)–Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for precision oncology, today reported financial results for the third quarter ended September 30, 2023 and provided recent business highlights. Third Quarter and Recent Highlights Achieved third quarter revenue of $18.2 million, representing an increase of 23% over the…
Click here to view original post
Copyright © 2023 Biotech Networks, LLC
